Stocks › GRX
Gabelli Healthcare & WellnessRx Trust
GRX·NYSE·
United States·USD
United States·USD$9.42
+0.03 (+0.32%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
GRX
Gabelli Healthcare & WellnessRx Trust · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
GRXS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of GRX by members of U.S. Congress · 2 on record
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
 Raúl M. GrijalvaHouse · D · AZ |
GRXGabelli Healthcare & WellnessRx Trust · Stock |
Sale $1,001 - $15,000 |
Sep 28, 2016 | Sep 19, 2016 | Filing ↗ |
| Raúl M. GrijalvaHouse · D · AZ |
GRXGabelli Healthcare & WellnessRx Trust · Stock |
Purchase $1,001 - $15,000 |
May 14, 2015 | Apr 28, 2015 | Filing ↗ |
Whale Activity
Position changes in GRX reported for 2025-12-31 by 1 tracked institutional filer
- Increased0
- New1
- Held0
- Decreased0
- Closed0
- No prior filing0
| Filer | Shares | Value | Change |
|---|---|---|---|
| Citadel Advisors LLC | 21.0K | $202K | new |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by GRX insiders, by quarter · Form 4
Recent Insider Transactions
209 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Saba Capital Management, L.P. | Purchase | +500 | $9.35 | $5K | Oct 2, 2026 | Form 4 ↗ |
| Saba Capital Management, L.P. | Purchase | +5,720 | $9.41 | $54K | Oct 1, 2026 | Form 4 ↗ |
| Saba Capital Management, L.P. | Purchase | +519 | $9.52 | $5K | Sep 30, 2026 | Form 4 ↗ |
| Saba Capital Management, L.P. | Purchase | +400 | $9.71 | $4K | Sep 11, 2026 | Form 4 ↗ |
| Saba Capital Management, L.P. | Purchase | +500 | $10.08 | $5K | Sep 3, 2026 | Form 4 ↗ |
| Saba Capital Management, L.P. | Purchase | +4,340 | $10.05 | $44K | Aug 27, 2026 | Form 4 ↗ |
| Saba Capital Management, L.P. | Purchase | +7,087 | $10.13 | $72K | Aug 21, 2026 | Form 4 ↗ |
| Saba Capital Management, L.P. | Purchase | +24.1K | $10.13 | $244K | Aug 19, 2026 | Form 4 ↗ |
| Saba Capital Management, L.P. | Purchase | +1,203 | $9.86 | $12K | Aug 14, 2026 | Form 4 ↗ |
| Saba Capital Management, L.P. | Purchase | +200 | $9.93 | $2K | Aug 11, 2026 | Form 4 ↗ |
| GABELLI MARIO JDirector | Purchase | +1,010 | $9.58 | $10K | Jan 12, 2026 | Form 4 ↗ |
| GABELLI MARIO JDirector | Purchase | +3,800 | $9.58 | $36K | Jan 12, 2026 | Form 4 ↗ |
| GABELLI MARIO JDirector | Purchase | +990 | $9.58 | $9K | Jan 8, 2026 | Form 4 ↗ |
| Saba Capital Management, L.P.10% owner | Purchase | +4,084 | $9.36 | $38K | Dec 17, 2025 | Form 4 ↗ |
| Saba Capital Management, L.P.10% owner | Purchase | +11.3K | $9.37 | $106K | Dec 16, 2025 | Form 4 ↗ |
| GABELLI MARIO JDirector | Purchase | +2,500 | $9.69 | $24K | Dec 3, 2025 | Form 4 ↗ |
| Saba Capital Management, L.P.10% owner | Purchase | +14.5K | $9.62 | $139K | Nov 25, 2025 | Form 4 ↗ |
| Saba Capital Management, L.P.10% owner | Purchase | +20.8K | $9.28 | $193K | Oct 23, 2025 | Form 4 ↗ |
| Saba Capital Management, L.P.10% owner | Purchase | +1,053 | $9.31 | $10K | Oct 22, 2025 | Form 4 ↗ |
| Saba Capital Management, L.P.10% owner | Purchase | +6,122 | $9.29 | $57K | Oct 21, 2025 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding GRX · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| Saba Closed-End Funds ETF Exchange Listed Funds Trust | 260.8K | $2.4M | 0.56% | May 31, 2026 |
| Saba Capital Income & Opportunities Fund II | 23.9K | $233K | 0.09% | Jul 31, 2026 |
| Multi-Hedge Strategies Fund Rydex Variable Trust | 236 | $2K | 0.01% | Jun 30, 2026 |
| Guggenheim Multi-Hedge Strategies Fund Rydex Series Funds | 84 | $794 | 0.01% | Jun 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list GRX's shares (CUSIP 36246K103), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming Gabelli Healthcare & WellnessRx Trust as client
No lobbying filings found naming Gabelli Healthcare & WellnessRx Trust as the client.
Government Contracts
Federal awards to Gabelli Healthcare & WellnessRx Trust · USAspending
No federal contract awards found for Gabelli Healthcare & WellnessRx Trust.
U.S. Patents
Recent USPTO applications naming Gabelli Healthcare & WellnessRx Trust
No USPTO patent applications found for Gabelli Healthcare & WellnessRx Trust.
Annual Financials
From GRX's 10-K filings · XBRL
No annual XBRL figures on record for GRX. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
No stock splits in GRX's price history.
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 8.01, 9.01Other eventsMay 7, 2026
EDGAR ↗
About Gabelli Healthcare & WellnessRx Trust
From SEC EDGAR company records
HeadquartersRYE, NY
IncorporatedDE
SEC CIK0001391437 ↗
Former namesGabelli Global Healthcare & WellnessRx Trust